摘要
The coronavirus disease 2019(COVID-19)pan-epidemic,resulting from infection with the 2019 novel coronavirus(2019-nCoV),also known as severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2),is currently the source of public health concern worldwide;however,treatment of this infection has been clinically challenging in many patients[1].Importantly,2019-nCoV is the third fatal coronavirus that has emerged in the past two decades,following SARS-CoV and the Middle East respiratory syndrome(MERS)-CoV[2].The numbers of confirmed cases of COVID-19 infection and related deaths are still rising.As of 9 March 2020.
基金
This work was supported by the grants from the Fundamental Research Funds for the Central Universities(2019FZA7001)
the Mega-Project of National Science and Technology for the 13th Five-Year Plan of China(2017ZX10202202002001)
the National Natural Science Foundation of China(81600497).
